rs15786

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000341676.9(ATP13A2):​c.3365C>T​(p.Pro1122Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.052 in 1,559,316 control chromosomes in the GnomAD database, including 2,562 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 197 hom., cov: 31)
Exomes 𝑓: 0.053 ( 2365 hom. )

Consequence

ATP13A2
ENST00000341676.9 missense

Scores

1
2
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.380

Publications

21 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, G2P, ClinGen
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023908615).
BP6
Variant 1-16986097-G-A is Benign according to our data. Variant chr1-16986097-G-A is described in ClinVar as [Benign]. Clinvar id is 293763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0593 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP13A2NM_022089.4 linkc.*124C>T 3_prime_UTR_variant Exon 29 of 29 ENST00000326735.13 NP_071372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP13A2ENST00000326735.13 linkc.*124C>T 3_prime_UTR_variant Exon 29 of 29 1 NM_022089.4 ENSP00000327214.8 Q9NQ11-1

Frequencies

GnomAD3 genomes
AF:
0.0394
AC:
5997
AN:
152062
Hom.:
197
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00961
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0229
Gnomad ASJ
AF:
0.0196
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.00748
Gnomad FIN
AF:
0.0880
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0608
Gnomad OTH
AF:
0.0253
GnomAD2 exomes
AF:
0.0397
AC:
6881
AN:
173142
AF XY:
0.0392
show subpopulations
Gnomad AFR exome
AF:
0.00917
Gnomad AMR exome
AF:
0.0132
Gnomad ASJ exome
AF:
0.0209
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0911
Gnomad NFE exome
AF:
0.0598
Gnomad OTH exome
AF:
0.0397
GnomAD4 exome
AF:
0.0534
AC:
75085
AN:
1407136
Hom.:
2365
Cov.:
31
AF XY:
0.0522
AC XY:
36274
AN XY:
694332
show subpopulations
African (AFR)
AF:
0.00874
AC:
281
AN:
32146
American (AMR)
AF:
0.0138
AC:
471
AN:
34128
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
548
AN:
24708
East Asian (EAS)
AF:
0.0000265
AC:
1
AN:
37756
South Asian (SAS)
AF:
0.0106
AC:
845
AN:
80048
European-Finnish (FIN)
AF:
0.0926
AC:
4664
AN:
50348
Middle Eastern (MID)
AF:
0.00833
AC:
47
AN:
5640
European-Non Finnish (NFE)
AF:
0.0605
AC:
65571
AN:
1084084
Other (OTH)
AF:
0.0456
AC:
2657
AN:
58278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
4505
9009
13514
18018
22523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2402
4804
7206
9608
12010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0394
AC:
5996
AN:
152180
Hom.:
197
Cov.:
31
AF XY:
0.0387
AC XY:
2877
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.00958
AC:
398
AN:
41534
American (AMR)
AF:
0.0229
AC:
350
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0196
AC:
68
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5170
South Asian (SAS)
AF:
0.00728
AC:
35
AN:
4810
European-Finnish (FIN)
AF:
0.0880
AC:
933
AN:
10606
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0609
AC:
4136
AN:
67966
Other (OTH)
AF:
0.0251
AC:
53
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
274
548
821
1095
1369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0508
Hom.:
807
Bravo
AF:
0.0339
ESP6500AA
AF:
0.0116
AC:
16
ESP6500EA
AF:
0.0569
AC:
181
ExAC
AF:
0.0323
AC:
3786
Asia WGS
AF:
0.00520
AC:
19
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kufor-Rakeb syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
2.5
DANN
Uncertain
0.98
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.52
T;T
MetaRNN
Benign
0.0024
T;T
MetaSVM
Benign
-0.48
T
PhyloP100
0.38
PROVEAN
Benign
0.38
N;N
REVEL
Benign
0.12
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0040
.;D
Vest4
0.13
ClinPred
0.0069
T
GERP RS
0.62
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs15786; hg19: chr1-17312592; API